SAN DIEGO, Calif. and WINTER HAVEN, Fla. (January 24, 2017)—ResMed, BMC and 3B Medical, today announced they have agreed on a global settlement of all litigation between the parties. BMC and 3B will be permitted to sell their existing products in exchange for royalty payments to ResMed, and ResMed will make a one-time settlement payment to 3B to close the Florida litigation between the two parties. The settlement did not include an admission of liability or wrongdoing by any party.